KNSA: Kiniksa Pharmaceuticals, Ltd. Kompaniya qiymatining sof foydaga nisbati

Kiniksa Corp - KNSA emitenti grafik logotipi

Kiniksa Pharmaceuticals ARCALYST ning monopol maqomi tufayli kamyob kasalliklar nishasida ustunlikka ega. Kompaniyaning foydaga nisbatan narx koeffitsiyenti ushbu ustunlikning bozor qiymatini aniq tasdiqlaydi, bunda 42.40 ushbu metrikaning bugungi qiymatini ifodalaydi. Biznesning barqarorligi iqtisodiy sikllarni hisobga olmagan holda, ilmiy ma'lumotlarga asoslangan. Tor portfel xatarlari asosiy dori vositasi uchun tasdiqlangan ko'rsatmalarning ro'yxatini kengaytirish orqali yumshatiladi.

Kiniksa (KNSA) Narxning foydaga nisbati: 04.07.2022 - 15.11.2026 davri uchun

Kiniksa Corp (KNSA) kompaniyasining tahliliy kesimlari

Kompaniyaning har tomonlama tahlili:Kiniksa KNSA
Kiniksa Pharmaceuticals Ltd brend mahsuloti

P/E koeffitsiyenti foydaning bir birligining bozor qiymatini o'lchaydi va aktivning kelgusidagi daromadlari kapitalizatsiya stavkalari bo'yicha investorlar kutganlarini aks ettiradi. GURU.Markets platformasida Kiniksa Pharmaceuticals (KNSA) ning bazaviy P/E koeffitsiyentini tahlil qilish orqali Kiniksa Pharmaceuticals kompaniyasining baholanishi adolatli ekanligini aniqlash mumkin, uning qiymati ixtisoslashtirilgan immunologiya segmentidagi kam uchraydigan autoimmun patologiyalarni davolashga mo'ljallangan dori vositalarining tijorat muvaffaqiyatiga bog'liqdir.

Muhim raqobatchilar

P/E multiplikatori Argenx|Narx-foyda koeffitsiyenti BNTX (BioNTech Group)|ABVX (abivax.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (admabiologics.com)|Biznesning o‘zini qoplash muddati protagonist-inc.com (PTGX)|IMVT - Narxning foydaga nisbati|Grifols SA (GRFS) - Narx-foyda koeffitsiyenti|Adaptive Biotechnologies Inc. (ADPT) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Celldex Therapeutics|Narx-foyda koeffitsiyenti AUPH|P/E multiplikatori biocryst.com|Narxning foydaga nisbati Vera Pharma (VERA)|Dianthus Therapeutics, Inc. - Narx-foyda multiplikatori|P/E multiplikatori PHVS (pharvaris.com)|AbCellera Bio (ABCL) - Kapitalizatsiyaning foydaga nisbati|TRML: Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati PGEN|PHAR: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Nektar Therapeutics Inc (NKTR)|Narx-foyda koeffitsiyenti UPB|Narx-foyda multiplikatori ZBIO (Zenas Biopharma, Inc.)|Narx-foyda koeffitsiyenti IMNM (Immunome Bio)|Biznesning o‘zini qoplash muddati Gossamer Bio, Inc.|P/E multiplikatori KALV (KalVista Pharma)|Septerna, Inc. (SEPN) - Kapitalizatsiyaning foydaga nisbati|PVLA - Narxning foydaga nisbati|SVRA - P/E multiplikatori|Rigel Pharmaceuticals Inc (RIGL) - Narxning foydaga nisbati|ANAB - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti ATXS|ENGN: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati RAPT Therapeutics (RAPT)|JBIO (Aerovate) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ACRS (Aclaris Therapeutics)|Kompaniya qiymatining sof foydaga nisbati KYTX|Tiziana Life Sciences - P/E multiplikatori|CABA: Narxning foydaga nisbati|VTYX: P/E multiplikatori|THTX (Theratechnologies, Inc) - Narxning foydaga nisbati|AVTX (Avalo Therapeutics, Inc.) - P/E multiplikatori|P/E multiplikatori Eledon Pharmaceuticals|Narxning foydaga nisbati Agenus Inc. (AGEN)|Narx-foyda koeffitsiyenti Climb Bio Inc. CLYM|P/E multiplikatori ZURA (Zura Bio Ltd)|ATYR - Narx-foyda koeffitsiyenti|ADAG - Narxning foydaga nisbati|IMA - P/E multiplikatori|STTK: P/E multiplikatori|Equillium Bio (EQ) - P/E multiplikatori|CNTB (connectbiopharm.com) - P/E multiplikatori|IMUX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ATRA|P/E multiplikatori InflaRx NV (IFRX)|X4 Pharmaceuticals, Inc. (XFOR) - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori adicetbio.com ACET|Celularity - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati INMB (INmune Bio Corp)|BRNS (Barinthus Bio) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati KZR (Kezar Life Sciences)|Narxning foydaga nisbati SAB Biotherapeutics Inc.|Akari Therapeutics Plc - Kapitalizatsiyaning sof foydaga nisbati|Narx-foyda koeffitsiyenti ENLV (Enlivex Therapeutics Ltd.)|Narx-foyda koeffitsiyenti Q32 Bio Inc QTTB|Narxning foydaga nisbati geovax.com GOVX|P/E multiplikatori edesabiotech.com EDSA|iBio Corporation - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CARM (carismatx.com)|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Bolt Bio (BOLT) - P/E multiplikatori|HCWB (HCW Biologics Inc) - P/E multiplikatori|Narx-foyda koeffitsiyenti Aptevo Therapeutics (APVO)|P/E multiplikatori AIM|Bozor narxining sof foydaga nisbati ADTX|P/E multiplikatori GRI (GRI Bio Corporation)|P/E multiplikatori XORTX Corp XRTX|HIND - Narxning foydaga nisbati|Revelation Biosciences (REVB) - Narx-foyda koeffitsiyenti|INDP (Indaptus Therapeutics, Inc.) - Narx-foyda koeffitsiyenti|Scinai Immunotherapeutics Ltd (SCNI) - P/E multiplikatori|CALI (CalciMedica Inc) - P/E multiplikatori|affimed.com - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati allakos.com (ALLK)|P/E multiplikatori HOOKIPA Pharma, Inc. (HOOK)|IGM Biosciences Inc. - Narx-foyda koeffitsiyenti|iTeos Therapeutics, Inc. (ITOS) - Kapitalizatsiyaning foydaga nisbati|OCEA: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati TCBP (TC BioPharm (Holdings) PLC)|THRD: P/E multiplikatori